Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CCNI mRNA | affects expression | 20382639
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CCNI mRNA | decreases expression | 20018196
|
D002994 |
Clofibrate |
PPARA protein affects the reaction [Clofibrate results in increased expression of CCNI mRNA] | affects reaction|increases expression | 17585979
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CCNI mRNA | increases expression | 20106945
|
D004391 |
Dust |
Dust results in decreased expression of CCNI mRNA | decreases expression | 17805423
|
D004958 |
Estradiol |
Estradiol affects the expression of CCNI mRNA | affects expression | 15598610
|
C071834 |
glycidamide |
glycidamide results in increased expression of CCNI mRNA | increases expression | 17822822
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in increased expression of CCNI mRNA | increases expression | 15585362
|
D011374 |
Progesterone |
Progesterone affects the expression of CCNI mRNA | affects expression | 17251523
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CCNI mRNA | decreases expression | 18796159
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 11752688 14514962 15322242 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.14 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
9.86 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.86 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.66 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.52 | 15845082 15380490 15665606 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.84 | 16675129 14630087 12948864 19861407 17289903 17018787 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.84 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.84 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.75 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.78 | 16924424 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
17.20 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
17.20 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.20 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
17.20 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.06 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 16354765 12621046 8697196 15668235 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.59 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.75 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.58 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
4.21 | 16707586 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.58 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.02 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.11 | 18566989 19148513 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.58 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.58 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
8.65 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.65 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.36 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.36 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.15 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.35 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.07 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.17 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.17 | 18670907 18850075 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.66 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.30 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.30 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.09 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.30 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.30 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.85 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.85 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.31 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.22 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.48 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.48 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.80 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.44 | 16810080 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.02 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.47 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.27 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.27 | 14600291 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
5.20 | 9802331 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.05 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.05 | 17393432 16525653 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.40 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11399792 11118676 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.05 | 16740699 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.29 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.91 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.13 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.56 | 15862959 16503802 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.00 | 19048282 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |